Tema心脏与健康主动型ETF HRTS 深 沪
已收盘 07-02 16:00:00 美东时间
37.2678
+1.026
+2.83%
华盛通- 最 高37.2678
- 今 开36.64
- 成交量 4818股
- 最 低 36.64
- 昨 收 36.2414
- 总市值 5664.70万
- 52周最高 37.2678
- 市盈率 静 --
- 换手率 0.32%
- 52周最低 26.7621
- 委 比 0.00%
- 总股本 152.00万
- 历史最高 37.2678
- 量 比 0.55
- 振 幅 1.73%
- 历史最低 24.8463
- 每 手 1
- 风险率 2.68%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多From Shingles To Superbugs: Eli Lilly Expands Infectious Disease Push In Billion-Dollar Buying Wave
Eli Lilly acquires Curevo, LimmaTech, and Vaccine Co. to expand its infectious disease portfolio and advance long-term disease prevention.
05-27 01:38
GLP-1 trials show mood improvement rather than the ‘Ozempic personality’ – Dr. Angela Fitch
Data from randomized controlled trials shows that most patients’ moods actually improve when treated for obesity with GLP-1 medications, according to Dr. Angela Fitch, Knownwell chief medical officer ...
04-17 22:13
Why Is Eli Lilly Stock Gaining Today?
Eli Lilly shares surged after FDA approval of its oral obesity drug Foundayo, boosting growth prospects in the weight-loss market.
04-02 01:08
'Roche Restricts Consulting Work With Big Four Firms To Cut Costs' - Bloomberg
https://www.bloomberg.com/news/articles/2026-03-24/roche-restricts-consulting-work-with-big-four-firms-to-cut-costs?utm_source=latest&utm_medium=share&utm_campaign=copy
03-24 23:43
Ultragenyx's Gene Therapy Study Shows Ammonia Reduction In Rare Metabolic Disorder
Ultragenyx Phase 3 gene therapy data shows reduced ammonia levels in rare disease patients, with further results expected in 2027.
03-13 01:35
UPDATE 5-Lilly reassures investors that weight-loss drug demand is strong, shares rise
Shares rise nearly 5% after upbeat forecast Drugmaker suggests demand for Zepbound and Mounjaro remains strong Lilly forecast earnings of $22.50 to $24.00 per share on an adjusted basis this year Adds...
2025-02-06 19:55
减肥药概念股美股盘初多数走高，安进涨13.8%，硕迪生物ADR涨1.4%，渤健BIIB涨0.9%，ETF HRTS涨0.8%，福泰制药涨0.1%，诺和诺德ADR则跌1%，Viking Therapeutics跌1.4%，礼来制药跌2%。
减肥药概念股美股盘初多数走高，安进涨13.8%，硕迪生物ADR涨1.4%，渤健BIIB涨0.9%，ETF HRTS涨0.8%，福泰制药涨0.1%，诺和诺德AD...
2024-05-03 21:34
若恐高“诺礼”股价，不妨考虑下这只跟踪“减肥药牛股”的ETF
Tema Cardiovascular and Metabolic(美股代码：HRTS)这一跟踪诸多专注于减肥药赛道医药企业的ETF可谓是非常好的选择，行业ETF投资组合具备多元化属性，波动性往往远小于个股。
2024-03-21 17:33
EXCLUSIVE: Tema ETFs' Innovative Thematic Investing Approach Targets New Opportunities Beyond The Fads
Tema ETFs is redefining thematic investing, focusing on long-term structural trends & precision in security selection rather than chasing short-term fads.
2023-12-02 00:14
